Medical technology company AOTI Inc has developed products that help to heal wounds by focusing oxygen on chronic wounds. These can include diabetic foot ulcers and pressure ulcers. The company acquired a negative pressure wound therapy device.
Diabetes levels are increasing, and this will provide the core market. The estimated global market for the company’s technology is $12bn. That requires regulatory approvals in additional geographic markets.
The board decided to come to AIM in June 2023. Existing shareholders sold 11.8 million shares in the placing. There were 22 trades during the...
